Stay updated on SNDX-5613 with Chemo in AML Clinical Trial
Sign up to get notified when there's something new on the SNDX-5613 with Chemo in AML Clinical Trial page.

Latest updates to the SNDX-5613 with Chemo in AML Clinical Trial page
- Check3 days agoChange DetectedThe history now includes a new entry dated 2026-07-16 with added Contacts/Locations and Study Status, along with an accompanying 2026-07-15 entry and the item '120'; the 2026-06-17 entry was removed from the record history.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision: v3.6.3 replaces Revision: v3.6.2 in the study record history, indicating an update to the page version rather than changes to the study information.SummaryDifference0.0%

- Check25 days agoChange DetectedA new revision entry labeled v3.6.2 has been added to the record history. The older v3.6.0 entry has been removed.SummaryDifference0.0%

- Check32 days agoChange DetectedDifference0.1%

- Check39 days agoChange DetectedThe study record now shows a new Phase 1b AML trial title and adds sections such as Check who can join, Find Contact Information, Eligibility, Outcome Measures, Study Design, Conditions, Study Description, Study Status, and Study Identification, reflecting the current version 3.6.0; the previous description of adding SNDX-5613 to standard chemotherapy for AML was removed.SummaryDifference0.8%

- Check46 days agoChange DetectedThe footer revision label changed from v3.5.4 to v3.5.5. This reflects a minor maintenance update to the page's history view and does not affect its content.SummaryDifference0.0%

Stay in the know with updates to SNDX-5613 with Chemo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-5613 with Chemo in AML Clinical Trial page.